BETA-BLOCKER

Clinical trials for BETA-BLOCKER explained in plain language.

Never miss a new study

Get alerted when new BETA-BLOCKER trials appear

Sign up with your email to follow new studies for BETA-BLOCKER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 2

Can a quick heart-rate drug prevent surgery-related heart damage?

Disease control Recruiting now

This study tests whether a short-acting beta-blocker called landiolol can keep heart rate below 90 beats per minute during and after major surgery in people with heart risks. About 114 adults aged 45 and older with at least two risk factors (like high blood pressure or heart dise…

Matched conditions: BETA-BLOCKER

Phase: PHASE4 • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control

Last updated May 15, 2026 11:53 UTC

BETA-BLOCKER

Get alerted when new BETA-BLOCKER trials appear

Can a quick heart-rate drug prevent surgery-related heart damage?